InvestorsHub Logo
Followers 4
Posts 1807
Boards Moderated 0
Alias Born 08/07/2006

Re: ampakineman post# 5961

Friday, 05/11/2007 4:45:59 PM

Friday, May 11, 2007 4:45:59 PM

Post# of 49059
Ampakineman,
I believe there is no way we test $2 before FDA. In fact, earlier today, I was watching $2.52 being defended, as they say, and in my mind, I called it as the down move's low.

You can scoff, as I'm sure you will, but I think the low has been set today (at least pre-FDA) at $2.52. Next week it slowly moves higher from here, IMHO. Once the options expire, there's no other way to play COR.

The bottom line is the science is compelling. The histo findings have been explained. We have waited 14+ months and counting. There is lots of BP interest. The binary event (FDA) is the next major hurdle and the prospects look very good.

As far as management credibility goes. Stoll has only been here a few years. A lot of the past mistakes were with different management. Stoll has pretty much delivered what he has said since he's been around and Cortex's house has never looked better.

If the FDA throws another roadblock up, there will be a big drop and COR will be running on fumes, but it will comeback and that would be the MOABO. But, should the FDA do the right thing and remove any dosing restrictions, COR is probably a 4-bagger from here by years end. These are compelling odds. I only wish I could load up on August options, because I would back the truck up. In another week, the only way to play the upside is by being long the stock.

In a few months, anything sub-$3 will look like a steal, IMHO.
MF4
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News